Your browser doesn't support javascript.
loading
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study.
Oh, Do-Youn; Algazi, Alain; Capdevila, Jaume; Longo, Federico; Miller, Wilson; Chun Bing, Jerry Tan; Bonilla, Carlos Eduardo; Chung, Hyun Cheol; Guren, Tormod K; Lin, Chia-Chi; Motola-Kuba, Daniel; Shah, Manisha; Hadoux, Julien; Yao, Lili; Jin, Fan; Norwood, Kevin; Lebellec, Loïc.
Affiliation
  • Oh DY; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Algazi A; Cancer Research Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Capdevila J; University of California San Francisco, San Francisco, California, USA.
  • Longo F; Vall d'Hebron Institute of Oncology (VHIO), Vall d'Hebron University Hospital, Barcelona, Spain.
  • Miller W; IOB-Quiron-Teknon, Barcelona, Spain.
  • Chun Bing JT; Hospital Universitario Ramón y Cajal, IRYCIS, CIBERONC, Madrid, Spain.
  • Bonilla CE; Segal Cancer Centre, Jewish General Hospital, Rossy Cancer Network, Montreal, Quebec, Canada.
  • Chung HC; Department of Oncology, McGill University, Montreal, Quebec, Canada.
  • Guren TK; Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Lin CC; Cebu Doctors University Hospital, Cebu City, Province of Cebu, Philippines.
  • Motola-Kuba D; Instituto Nacional de Cancerologia, Bogota, Province of Distrito Capital de Bogota, Colombia.
  • Shah M; Fundacion CTIC (Centro de Tratamiento e Investigación sobre Cáncer), Bogotá, Colombia.
  • Hadoux J; Department of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Yao L; Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Jin F; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.
  • Norwood K; COMOP A.C., Clinical Investigation, Mexico City, Mexico.
  • Lebellec L; Ohio State University Comprehensive Cancer Center, Columbus, Ohio, USA.
Cancer ; 129(8): 1195-1204, 2023 04 15.
Article in En | MEDLINE | ID: mdl-36748723
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular / Antineoplastic Agents, Immunological Limits: Humans Language: En Journal: Cancer Year: 2023 Type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Thyroid Neoplasms / Adenocarcinoma, Follicular / Antineoplastic Agents, Immunological Limits: Humans Language: En Journal: Cancer Year: 2023 Type: Article